2021
DOI: 10.1080/13691066.2021.1894749
|View full text |Cite
|
Sign up to set email alerts
|

Technology spillovers and capital gains in corporate venture capital investments: evidence from the biopharmaceutical industry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
8
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(10 citation statements)
references
References 46 publications
2
8
0
Order By: Relevance
“…Previous work has documented an investor bias against female entrepreneurs (Ewens & Townsend, 2020;Guzman & Kacperczyk, 2019;Hebert, 2020) and that female borrowers face tighter credit availability or less favorable loan terms (Agier & Szafarz, 2013;Alesina, Lotti, & Mistrulli, 2013;Asiedu, Freeman, & Nti-Addae, 2012;Bellucci, Borisov, & Zazzaro, 2010;Mascia & Rossi, 2017;Muravyev, Talavera, & Schäfer, 2009). Recent experimental work has pinpointed to loan officers' gender bias as a source of gender disparities in entrepreneurial finance (Alibhai et al, 2019;Brock & De Haas, 2023;Zhang, 2023). Closest to our study, Brock and De Haas (2023) provide causal evidence for gender discrimination in entrepreneurial lending.…”
Section: Introductionsupporting
confidence: 66%
“…Previous work has documented an investor bias against female entrepreneurs (Ewens & Townsend, 2020;Guzman & Kacperczyk, 2019;Hebert, 2020) and that female borrowers face tighter credit availability or less favorable loan terms (Agier & Szafarz, 2013;Alesina, Lotti, & Mistrulli, 2013;Asiedu, Freeman, & Nti-Addae, 2012;Bellucci, Borisov, & Zazzaro, 2010;Mascia & Rossi, 2017;Muravyev, Talavera, & Schäfer, 2009). Recent experimental work has pinpointed to loan officers' gender bias as a source of gender disparities in entrepreneurial finance (Alibhai et al, 2019;Brock & De Haas, 2023;Zhang, 2023). Closest to our study, Brock and De Haas (2023) provide causal evidence for gender discrimination in entrepreneurial lending.…”
Section: Introductionsupporting
confidence: 66%
“…The empirical research determines specific objectives either through interviews (Siegel et al 1988;Kanbach and Stubner 2016;Szalavetz and Sauvage 2023), by the existence of strategic relationships (Kang et al 2021), or by CV outcomes, including patents for strategic objectives or the return on investment (ROI) for financial objectives (Dushnitsky and Lenox 2005;Huang and Madhavan 2021). Also, the relationship between strategic objectives and different CV modes and governance forms within a single mode has been discussed in detail.…”
Section: Prioritization Of Objectives (Primary Objectives)mentioning
confidence: 99%
“…The dimension can be described by multiple factors, including financial support through funding (Pauwels et al 2016;Wang et al 2021), and non-financial support through formal and informal linkages of operations (Burgers et al 2009;Johnson 2012), employee mobility (Kim and Steensma 2017;Cirillo 2019), mentoring, networking, and facility services (Sorrentino and Williams 1995;Kanbach and Stubner 2016;Shankar and Shepherd 2019), which enable synergies between the corporation and the venture (Haslanger et al 2022). Knowledge flow is also commonly represented either as patenting (Di Lorenzo and van de Vrande 2019) or by strategic alliances, such as licensing or collaborative R&D (Gonzales and Ohara 2019;Kang et al 2021). The integrational level is also, for acquisitions, an essential factor influencing the innovation outcomes of young ventures (Puranam et al 2006).…”
Section: Link To the Corporate Firmmentioning
confidence: 99%
“…With the accelerating economic globalization process and the increasingly complex market environment, the biopharmaceutical industry's sustainable development is inseparable from rich knowledge, technology, and other resources [5]. As an effective way for Int.…”
Section: Introductionmentioning
confidence: 99%
“…With the accelerating economic globalization process and the increasingly complex market environment, the biopharmaceutical industry’s sustainable development is inseparable from rich knowledge, technology, and other resources [ 5 ]. As an effective way for firms to acquire diversified knowledge, a knowledge search helps enterprises enrich their knowledge base, improving their competitive advantages [ 6 ].…”
Section: Introductionmentioning
confidence: 99%